Eye Care and Cataract Monitoring on Long-Term Steroids in Duchenne
Long-term steroids in Duchenne raise the risk of cataracts. Why eye monitoring is part of steroid care, what symptoms to watch for, and how often to check.
Eye care is an easily overlooked part of looking after a child with Duchenne muscular dystrophy who takes corticosteroids long term. Daily steroids such as prednisone, prednisolone, and deflazacort are central to Duchenne care, but among their side effects is an increased risk of cataracts, a clouding of the lens of the eye. Because this develops slowly and painlessly, regular eye checks are part of steroid care rather than something to arrange only once symptoms appear.
This post explains the eye risks of long-term steroids and why monitoring matters. The monitoring schedule for any child is set by the care team.
Why steroids affect the eyes
Long-term corticosteroid use is a recognised cause of cataracts, including in children treated for Duchenne. (Corticosteroids for the treatment of Duchenne muscular dystrophy, Cochrane Review, PubMed) The type linked to steroids often forms at the back of the lens and can affect vision as it grows.
Less commonly, steroids can raise the pressure inside the eye, which is why eye reviews check for more than cataracts alone.
Why monitoring matters more than symptoms
Cataracts from steroids usually develop gradually and without pain. A child may not notice or report a slow change in vision, and may simply adapt to it. By the time a problem is obvious, it may already be more advanced.
This is why guidance on long-term steroid use in Duchenne includes planned monitoring for side effects rather than relying on symptoms. (Management of side effects for long-term corticosteroid treatment in Duchenne muscular dystrophy, French guidelines, PubMed) For background on the medicines, see corticosteroids in DMD.
What eye monitoring involves
Eye care for a child on long-term steroids usually means a regular review by an optician or ophthalmologist, often once a year, with more frequent checks if a problem appears. The review looks for early lens changes and checks the pressure inside the eye.
If a cataract is found, it does not always need immediate treatment. Small cataracts are often simply watched, and only those affecting vision need surgery.
What families can watch for between checks
While monitoring should not wait for symptoms, families can still report changes promptly. Worth mentioning to the team are complaints of blurred or cloudy vision, increased sensitivity to glare or bright light, or a child holding screens or books unusually close.
Reporting these does not replace scheduled checks, but it can prompt an earlier review.
Eye care alongside the rest of steroid monitoring
Eye review sits alongside the other checks that come with long-term steroids, including growth, weight, blood pressure, bone health, and adrenal function. For background, see endocrine care in DMD, bone health in DMD, and adrenal insufficiency and steroid sick-day rules in Duchenne.
Seeing eye care as one part of a planned monitoring routine keeps it from being forgotten.
What is still uncertain
The exact risk for an individual child, and the best monitoring interval, vary with the steroid, the dose, and the duration of treatment. What is consistent is that long-term steroids justify regular eye checks, because catching changes early gives the most options.
For related reading, see corticosteroids in DMD, endocrine care in DMD, adrenal insufficiency and steroid sick-day rules in Duchenne, bone health in DMD, and the reported piece Two Mothers, Two Realities.
Disclaimer: This post is informational and does not constitute medical advice. Decisions about diagnosis or treatment must be made with a qualified care team.